L-Carnitine, Protection Against Cisplatin Nephrotoxicity in Rats: Comparison with Amifostin Using Quantitative Renal Tc99m DMSA Uptake


Yürekli Y., Ertay T., Ünak P., Yenisey Ç., Biber F. Z., Medine E. İ.

Molecular Imaging and Radionuclide Therapy, vol.20, no.1, pp.1-6, 2011 (Peer-Reviewed Journal)

  • Publication Type: Article / Article
  • Volume: 20 Issue: 1
  • Publication Date: 2011
  • Journal Name: Molecular Imaging and Radionuclide Therapy
  • Journal Indexes: TR DİZİN (ULAKBİM)
  • Page Numbers: pp.1-6
  • Dokuz Eylül University Affiliated: Yes

Abstract

Objective: In this study, we aimed to investigate the cytoprotective effect of L-carnitine against cisplatin-induced nephrotoxicity and to compare its efficacy with that of amifostin by quantitative renal Tc 99m DMSA uptake.

Material and Methods: Male Wistar rats were randomly divided into six groups of six animals each. 1) Control (saline; 5 ml/kg intraperitoneally); 2) L-carnitine (CAR; 300 mg/kg intraperitoneally); 3) Amifostine (AMI; 200 mg/kg intraperitoneally); 4) Cisplatin (CIS; 7 mg/kg intraperitoneally); 5) Cisplatin plus L-carnitine (CIS + CAR); 6) Cisplatin plus amifostine (CIS + AMI). L-carnitine and amifostine were injected 30 minutes before cisplatin in Group 5 and 6. Tc 99m DMSA, 7.4 MBq/0.2 ml, was injected through the tail vein 72 hours after the drug administration. Rats were killed and kidneys removed by dissection 2 hours after the injection of the radiopharmaceutical. The percentage of the injected dose per gram of kidney tissue (% ID/g) was calculated. Renal function was monitored by measuring BUN and plasma levels of creatinine. Lipid peroxidation and glutathione content were determined by measuring malondialdehyde (MDA) and reduced glutathione (GSH) in kidney tissue homogenates.

Results: Tc 99m DMSA uptake per gram tissue of the kidney as % ID/g was 29.54 +/- 4.72, 29.86 +/- 7.47 and 26.37 +/- 4.54 in the control, CAR and AMI groups respectively. % ID/g was the lowest of all the groups, 11.60 +/- 3.59 (p<0.01), in the cisplatin group. Carnitine or amifostine administration 30 minutes before cisplatin injection resulted a significant increase in % ID/g, 21.28 +/- 7.73 and 18.97 +/- 3.24 respectively, compared to those of cisplatin-treated rats (p<0.002). A marked increase in plasma BUN and creatinine indicating nephrotoxicity and acute renal failure was observed in the cisplatin-treated group. MDA and GSH levels were concordant with cisplatin-induced oxidative stress in the kidney tissue.

Conclusion: The results showed that L-carnitine significantly attenuates the cisplatin-induced nephrotoxicity as amifostin.